The potential benefits of these medications, especially in reducing the risk of heart disease, far outweigh the theoretical risks for most patients
Studies have found that those using Semaglutide GLP-1 lost up to 10% of their body weight over a period of 16 weeks, compared to those not using Semaglutide GLP-1, who lost an average of 3%
The trial showed that a higher proportion of patients treated with tirzepatide achieved glycemic targets, with 82% to 86% reaching an HbA1c level of less than 7.0% and 27% to 46% reaching an HbA1c level of less than 5.7%
The Wegovy pill, available in doses from 1.5 mg to 25 mg, can be purchased at more than 70,000 pharmacies in the United States, including chains such as CVS and Costco, and telehealth providers including Ro, LifeMD and Weight Watchers
When blood glucose levels are elevated, GLP-1 binding to beta-cell receptors triggers intracellular signaling cascades that enhance insulin synthesis and release
10.1111/dom.14480 10 BoseA